Publications by authors named "D Blasco"

Introduction: The (IDEAL) Study is a randomized clinical trial investigating the psychosocial, behavioral, and cognitive impacts of apolipoprotein E () genotype disclosure for late-onset Alzheimer's disease (AD) among Latinos.

Methods: We used address-based sampling to recruit English- and Spanish-speaking Latinos aged 40-64 living in northern Manhattan for a community-based Baseline Survey about their knowledge and opinions about AD. Participants eligible for the clinical trial were invited to complete an Introductory Session, including AD and genetics education and informed consent, before undergoing genotyping for .

View Article and Find Full Text PDF

We report the syntheses, spectroscopic analyses, and solid-state structural evidence of a quasi-planar aromatic [38] -ethylene bridged octaphyrin (1.2.1.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the clinical high risk for psychosis (CHR-p) syndrome, distinguishing between two types of stigma: 'labelling-related' stigma stemming from the identification itself and 'symptom-related' stigma from experiencing mental health symptoms.
  • It compares the rates and effects of these stigmas on self-esteem, social support, and quality of life in individuals identified as CHR-p.
  • Results showed that symptom-related stigma was more strongly linked to negative psychosocial effects, while labelling-related stigma involved higher levels of secrecy, indicating the need for interventions that address the full stigma experience for those at risk.
View Article and Find Full Text PDF

Background: The increasing availability of genetic testing for late-onset diseases such as Alzheimer's disease necessitates understanding public perceptions and experiences of such testing among at-risk populations.

Objectives: To assess (a) prior uptake of genetic testing (both in medical and direct-to-consumer settings), (b) future interest in genetic testing for late-onset conditions (e.g.

View Article and Find Full Text PDF

Workplace wellness programs are an emerging avenue for health-related genetic testing, with some large employers now offering such testing to employees. Employees' knowledge and concerns regarding genetic discrimination may impact their decision-making about and uptake of workplace genetic testing (wGT). This study describes employed adults' objective knowledge of the Genetic Information Nondiscrimination Act (GINA) and evaluates how this knowledge correlates with attitudes and beliefs regarding wGT.

View Article and Find Full Text PDF